Market Cap: $264.94M
BP
Bicycle Therapeutics plc
BCYC
NASDAQ (NASDAQ Global Select)USD
Market Cap: $264.94M
Bicycle Therapeutics: Pioneering Innovative Therapeutics with Bicycle® Technology Bicycle Therapeutics Plc, a clinical-stage pharmaceutical company based in Cambridge, England, is at the forefront of…
Bicycle Therapeutics Enhances Workforce with Inducement Awards Amid Ongoing Clinical Trials Bicycle Therapeutics plc, a clinical-stage pharmaceutical company recognized for its innovative Bicycle® mol…
Bicycle Therapeutics Expands Workforce with Inducement Awards to New Employees Bicycle Therapeutics plc announces the granting of inducement awards to 18 new employees as part of its commitment to att…
Bicycle Therapeutics Set to Showcase Innovative Therapeutics at J.P. Morgan Conference Bicycle Therapeutics plc, a clinical-stage pharmaceutical company headquartered in Cambridge, England, is poised…
Bicycle Therapeutics Advances Innovative Therapeutics at J.P. Morgan Healthcare Conference Bicycle Therapeutics plc, a clinical-stage pharmaceutical company headquartered in Cambridge, England, is poi…
Bicycle Therapeutics Expands Workforce with Inducement Awards Amid Ongoing Drug Development Bicycle Therapeutics plc, a clinical-stage pharmaceutical company specializing in innovative therapies, rece…
Bicycle Therapeutics Advances NECTIN4 Targeting Cancer Treatments Bicycle Therapeutics plc, a pioneering pharmaceutical company based in Cambridge, England, showcases significant advancements in cance…
Bicycle Therapeutics Expands Clinical Advisory Board to Strengthen Oncology Focus Bicycle Therapeutics plc, a leading pharmaceutical innovator specializing in therapeutics based on its proprietary bic…
Bicycle Therapeutics Expands Talent Pool with New Employee Inducement Awards Bicycle Therapeutics Plc (NASDAQ: BCYC), a clinical-stage pharmaceutical company based in Cambridge, England, makes a signi…
Bicycle Therapeutics Strengthens Talent Pool with Inducement Awards for New Employees Bicycle Therapeutics Plc, a clinical-stage pharmaceutical company based in Cambridge, England, makes a significant…
Bicycle Therapeutics Set to Present Promising Data at SABCS 2024 Bicycle Therapeutics Plc, a trailblazer in the field of targeted cancer therapies, prepares to unveil significant findings on its thera…
Bicycle Therapeutics Set to Showcase Promising Data on Zelenectide Pevedotin at SABCS 2024 Bicycle Therapeutics plc, an innovative pharmaceutical company based in Cambridge, England, is gearing up to…
Bicycle Therapeutics Expands Team to Accelerate Innovative Drug Development Bicycle Therapeutics plc, a clinical-stage pharmaceutical company based in Cambridge, UK, is reinforcing its commitment to a…
Bicycle Therapeutics Advances in Cancer Therapeutics Through Innovative Imaging Data Bicycle Therapeutics plc, a pioneering Cambridge-based pharmaceutical company, makes significant strides in cancer…
Bicycle Therapeutics’ Innovative Advances in Cancer Imaging Bicycle Therapeutics plc, a pioneering Cambridge-based pharmaceutical firm, marks a notable milestone with its proprietary bicyclic peptide…